Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

PolyVascular, leading the effort to improve children's lives with a novel polymeric transcatheter valve (PTV) for children, announced that it was awarded a $2 million Small Business Innovation Research (SBIR) Phase II grant earlier this year to bring its polymeric stent-mounted valve (SMV) to clinical trials within the next two years in an effort to address pediatric congenital heart disease (CHD), which affects over 1 million patients around the world.

News | Pediatric Cardiology

PolyVascular Awarded $2 Million Small Business Innovation Research Grant to Bring the First Polymer-Based Heart Valve for Children to Clinical Trials

May 13, 2021 — PolyVascular, leading the effort to improve children's lives with a novel polymeric transcatheter valve ...

May 13, 2021

News | Endovascular Aortic Repair

Low Profile Thoracic Aortic Endograft Device Reduces Complications and Expands Patient Pool

May 12, 2021 — Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a ...

May 12, 2021

The BioCardia cardiac stem cell CardiAMP trial is a Phase III study looking at the efficacy of using stem cells to improve heart function in heart failure patients. It is the first trial for this technology to reach Phase III trial.

Feature | Stem Cell Therapies | By Simon H. Stertzer, M.D.

Is Cardiac Cell Therapy Worth Another Look?

Heart failure remains an unheralded global pandemic, costing society billions of dollars each year.[1,2] Projections ...

May 11, 2021

The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE) have joined the International Contrast Ultrasound Society (ICUS) in recognizing the relatively low risk and important clinical benefits of ultrasound contrast agents (UCAs), which are used routinely around the world to help detect heart disease, stratify the risk of heart attack or stroke, identify and characterize tumors throughout the abdomen, and monitor the effectiveness of cancer therapies in adul

News | Contrast Media

Medical Societies Support Safety and Benefits of Ultrasound Contrast Agents

May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE ...

May 11, 2021

Patients hospitalized with COVID-19 may be at risk of developing heart failure even if they do not have a previous history of heart disease or cardiovascular risk factors, a new Mount Sinai study shows.

News | Heart Failure

Patients Hospitalized With COVID-19 Have a Small Risk of Heart Failure

May 11, 2021 — Patients hospitalized with COVID-19 may be at risk of developing heart failure even if they do not have a ...

May 11, 2021

Videos | Structural Heart

VIDEO: VARC-3 Helps Standardize Structural Heart Taxonomy and Research

Philippe Géneréux, M.D., director of the structural heart program at Atlantic Health System’s Morristown Medical Center ...

May 10, 2021

An example of a patch type cardiac monitor from Vital Connect. These types of inexpensive, stick-on wearable monitors have seen a tremendous increase in use over the past few years, replacing traditional Holter monitors.

News | Wearables

Wearable Cardiac Devices Market Will See Rapid Expansion in Coming Years

May 6, 2021 — The wearable cardiac devices market is set to grow from its current market was valued at more than $1.2 ...

May 06, 2021

Videos | Cath Lab

VIDEO: Avoiding Higher Risk Cath Lab Patients May Not Improve Outcomes Scores

Ashwin Nathan M.D., a cardiology fellow in the division of Cardiovascular Medicine at the Hospital of the University of ...

May 05, 2021

Avoiding high-risk PCI procedures does not improve hospital scores according to a study presented at SCAI 2021. CTO procedure at Henry Ford Hospital, Detroit. Photo by Dave Fornell.

News | Cardiovascular Business

Avoiding High-risk Cath Lab Procedures Does Not Necessarily Improve Hospital Scores

May 5, 2021 — A late-breaking study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 202 ...

May 05, 2021

A nurse checking an ECMO system being used to support a critically ill COVID-19 patient at Banner Health in Phoenix. ECMO can offer both hemodynamic support and oxygenation for COVID patients who otherwise cannot get enough pulmonary support from ventilators, or are in danger of organ failure.

News | ECMO Systems

May 4, 2021 – A new study, presented today at the 2021 American Association for Thoracic Surgery (AATS) 101st annual ...

May 04, 2021

If MitraClip Fails 95 Percent of Patients Will Need Full Surgical Valve Replacement according to a late-breaking study at the AATS 2021 meeting. #AATS2021

News | Heart Valve Technology

If MitraClip Fails 95 Percent of Patients Will Need Surgical Valve Replacement

May 4, 2021 – A new study, presented at the 2021 American Association for Thoracic Surgery (AATS) 101st annual meeting ...

May 04, 2021

8 Essential Steps for a Successful cardiovascular information system (CVIS) or PACS Implementation. Getty Images

Feature | Cardiovascular Information Systems (CVIS) | By Jef Williams

8 Essential Steps for a Successful CVIS or PACS Implementation

You have selected a vendor for your new cardiovascular information system (CVIS) or PACS. Congratulations. Most likely ...

May 04, 2021

The NuMED 10-zig Covered CP (CCP) balloon expandable covered stent. It is used for repair of sinus venosus atrial septal defects (SVASD). #SVASD #SCAI2021 #congenitalheart #

News | Congenital Heart

Global registry Shows Longer Stent Minimizes Procedure Complications in Sinus Venosus Atrial Septal Defects

May 1, 2021 - An analysis of a new international registry reveals benefits of using a longer covered stent for ...

May 01, 2021

Videos | Structural Heart

VIDEO: Socioeconomic and Geographic Access to TAVR Programs is Limited

Ashwin Nathan M.D., a cardiology fellow at the Hospital of the University of Pennsylvania, presented a late-breaking ...

April 30, 2021

The Medtronic Harmony transcatheter pulmonary valve (TPV) system offers a less invasive treatment option for patients with a congenital heart defect irregularity in their right ventricular outflow tract (RVOT) that requires a pulmonary valve placement to restore valve function.

Feature | Structural Heart | Dave Fornell, Editor

One-year Results of the Harmony Transcatheter Pulmonary Valve Trial Presented at SCAI 2021

April 30, 2021 — New study results validate the effectiveness of the Medtronic Harmony transcatheter pulmonary valve ...

April 30, 2021